Outline I. New Drug Review Process: First Principles II. FDA Model of Serial Evaluation:Investigational New Drug (IND) .... Pre-Clinical studies .... Clinical Trials Phases I ? IV New Drug Application (NDA)Post-Marketing Surveillance III. Life Science Reviewers: Roles/Opportunities Pharmacology Physiology Toxicology PathologyMolecular Biology Chemistry Statistical ScienceVeterinary Med9447
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.